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It is important to remember that the destruction of the
immune system is related to the kinetics of viral replication.
In most cases increased viral replication is associated with
a more rapid destruction of the immune system and a more
rapid progression of HIV disease.  
The hallmark of HIV infection is a loss of CD4+
lymphocytes.  The loss of lymphocytes occurs for a variety
of reasons, among them direct destruction of CD4+ cells,
immunologically mediated CD4+ loss and apoptosis
(programmed cell death), which is related to the intense
and ongoing immune activation invariably present
throughout the course of HIV disease.  In early disease the
loss of CD4+ cells is compensated for by an increased
output and the CD4+ lymphocyte homeostasis is largely
maintained.  This situation continues for the first few years,
but progressive events occur in lymphoid tissue which
compromise the output of CD4+ lymphocytes. 
IMMUNE RESPONSES TO HIV INFECTION
Cytotoxic T cells (CTLs)
Studies in persons with chronic HIV-infection have
detected both cellular and humoral immune responses to
HIV.2 As in other chronic viral infections cytotoxic T
lymphocytes are generated in response to infections that
inhibit virus replication by at least two mechanisms.  In the
first instance direct killing of cells infected with HIV occurs.
Small peptide fragments form complexes with class 1 HLA
molecules and these are presented on the cell surface to
trafficking CTLs.  The presence of a viral peptide (usually 
9 - 10 amino acids in length) within the peptide-binding
cleft of a class 1 molecule is a signal to the immune system
that a foreign pathogen is present within that cell.  This
then triggers the CTL to kill the infected cell through a
direct recognition mediated by the T-cell receptor (TCR) on
the CTL.  The killing of the cell results from a production of
perforins and granzymes secreted by the CTL.  
The second mechanism exerted by the CTL is the release of
soluble antiviral factors via the activated CTL.  These include
the beta-chemokines (RANTES, MIP-1alpha and MIP-
1beta).  There is also a further soluble factor, which is in the
process of being defined.  This factor, termed the CD8+
antiviral factor (CAF), is thought to suppress viral
replication at the transcriptional level.  This occurs in a
non-major histocompatibility complex (MHC) manner.3
Each HLA class 1 allele is slightly different and therefore
there is variation in the viral peptides that are able to bind
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The advent of highly active antiretroviral combination therapy (HAART) has resulted in significantly improved survival of
patients and a reduction in the progression of human immunodeficiency virus (HIV) infection.1
At the root of these clinical benefits is a dramatic reduction in HIV viral load.  HAART induces a sustained effective
suppression of HIV replication in most patients and leads to a preservation or restoration of immune function.  
The restoration of an impaired immune system is assessed by clinical parameters, immunological changes which can be
measured in the laboratory and a marked reduction in the morbidity and mortality of patients.  To understand the
features of immune restoration it is necessary to review the immunopathogenesis of HIV infection and highlight areas
where improvement of function occurs with HAART.
THE IMMUNOPATHOGENESIS OF HIV INFECTION
MECHANISM OF CD4+ CELL LOSS
■ Direct cytotoxic effect of viral replication
■ Immunologically mediated destruction 
■ Apoptosis mediated by immune activation
■ Bone marrow stem cell failure
■ Thymic failure of CD4+ cell programming
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to a specific allele.  As over 50 class 1 alleles have now been
defined it can be seen that many different viral peptides
can be bound and presented, and consequently there is a
considerable variation between individuals with regard to
their immune response.  The importance of CD8+ CTLs is
seen throughout the course of HIV disease.  It is an
important mechanism to curtail HIV replication at primary
infection, and high levels of CD8+ cells are especially seen
in persons who are slow progressors (so called long-term
non-progressors).
Virus-specific T-helper cells  
In addition to CTLs the cellular immune response is also
associated with the generation of virus-specific T-helper
cells.  These cells are required for the maintenance of CTL
function.  CD4+ T-helper cells recognise viral proteins that
have been taken up in lysosomes of antigen-presenting
cells (APCs).  There they are processed to smaller peptides
and then presented at the cell surface within the peptide-
binding groove of class 2 HLA molecules.  The presence of
a viral peptide in the class 2 binding group elicits a CD4+
helper response, which in turn orchestrates an overall
immune response.  The CD4+ helper effect is mediated by
direct cell-to-cell interactions and the release of a number
of cytokines.  The viral peptides that service targets for the
T-helper response tend to be larger than those involved in
CTL recognition (12 - 15 amino acids in length).
Antibodies  
Neutralising antibodies are detected in HIV infection and
are targeted against a number of different epitopes.  These
include antibodies directed against portions of the
envelope protein that are involved in virus entry to the cell
(V3 loop antibodies) and in CD4+ binding (CD4+ binding
site antibodies).4 One of the limitations of neutralising
antibody responses is that they are typically type-specific.
This means that antibodies generated against one
particular virus may not cross-react with others.  This has
implications for immune control since viruses continue to
mutate within the infected host and are constantly
escaping immune detection.  
Fig. 1. Inhibition of HIV-1 replication.
IMMUNE ACTIVATION
Positive consequences Negative consequences Immunodeficiency
■ Expression of activation ■ Promotes reverse transcription ■ Chronic immune system dysfunction
antigens — HLA-DR, CD38 ■ Viral integration ■ Reduction of function of 
■ Activation of monocytes ■ Upregulates viral replication macrophages, neutrophils, dendritic 
■ Lymph node hyperplasia ■ Induces expression in cells and NK cells leading to decrease
■ Increased cytokine expression latently infected cells in chemotaxis, microbial killing,
■ Antiviral effects ■ Spread to activated cells altered cytokine expression and
■ Removal of infected cells ■ Anergy of immune cells antigen presenting function
…. normal vigorous immune ■ Perturbation of T-cell repertoire ■ Decreased CD4+ responses to recall
response …. chronic immune activation antigens, allo-antigens and mitogens
■ Decreased cytokine production
especially IL-2
■ Decreased CD8 responses and
CTL functions
…. immune exhaustion
Fig. 2. Virus-specific T-helper cells mechanism.
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IMMUNE ACTIVATION
One of the hallmarks of HIV infection is a chronic immune
activation, which persists for years.  Immune activation is a
necessary component in any immune response to infecting
pathogens, but after the acute event the immune
activation usually subsides.  In HIV disease the persistent
generation of both humoral and cellular escape mutants
means that in effect the immune system is constantly
facing a new pathogen, and this leads to a persistent state
of immune activation. The negative consequences of
immune activation are induction of activation of cells,
which in turn leads to productive infection of latently
infected cells and also makes uninfected cells more
susceptible to infection.  Immune activation also promotes
apoptosis of uninfected CD4+ lymphocytes and thus
contributes to the overall CD4+ cell loss.
Both CD4+ and CD8+ cells all have surface expression of
molecules such as CD38 and HLA-DR that are associated
with immune activation.  Recent studies5 have shown that
high-level expression of CD38 on CD8+ cells is a powerful
predictor of HIV disease progression.   CD38 expression also
correlates with lymphocyte susceptibility to programmed
cell death.    
IMMUNE PHENOTYPIC CHANGES
The CD4+ lymphocyte compartments consist of two
functional subsets separated on the basis of expression of
certain cell surface markers.  Naïve cells express CD45RA
and CD62L whereas memory cells express CD45RO.  In
principle, naïve cells are newly generated through a
selection process in the thymus.  Naïve cells have the
potential to generate immune responses to newly
encountered antigens but are not particularly capable of
cytokine expression or of effector cell activity.  After
exposure to antigenic peptides expressed on cell surface
class 1 MHC molecules (CD8+ cells) or those on cell surface
class 2 MHC molecules (CD4+ cells), naïve cells evolve into
effector cells and will eventually express the memory
phenotype.  These cells are capable of an array of cytokine
expression and also possess effector cytolytic activity.
After antigenic exposure the majority of effector cells die
by apoptosis and a minority revert to the memory state.
These cells are capable of rapid responses to previously
encountered antigens providing the classic secondary or
anamnestic response to previously encountered antigens.
In healthy adults approximately 50% of circulating cells are
of the naïve phenotype and 50% of memory cells. 
CYTOKINES-TH1/TH2 AXIS
T-helper lymphocytes consist of two distinct subsets
designated TH1 and TH2.  The differentiation into the
subsets is based on the cytokine profiles elaborated by the
individual subsets.  Cytokines are soluble factors produced
by immune cells that subserve immunological functions.
The TH1-subset is associated with the production of
interleukin-2 (IL-2) and gamma interferon (IFN-γ).  The
TH1-response promotes cell-mediated immunity and
enhances CD8+ lymphocyte function.  This is seen in early
disease and is also part of immune restoration after HAART
is initiated.  The TH2-response is associated with the
production of IL4, IL5, IL6 and IL10.  The TH2-response is
linked to an enhanced humoral activity with activation of B
cells.  There is a cross-regulation between the two
functional subsets (Fig. 3).  During progression of HIV
infection there is a switch from a TH1 to a TH2 cytokine
profile, which is often reversed following the increase in
CD4+ cell numbers and function with HAART. 
THE T-CELL REPERTOIRE
An enormous diversity of foreign antigens, approximately
1013 to 1015, are recognised by T cells through the T-cell
receptor to antigen (TCR).  This comes about following
intrathymic maturation by the diversity of recombination
in the gene fragments that encode the TCR, with each TCR
providing the specificity for a given antigen.  The overall
diversity of the T-cell repertoire decreases with age and
also following chronic exposure to antigens.  This process is
accelerated throughout the course of HIV infection because
of the state of immune activation and also because thymic
output decreases once the thymus gland itself becomes
infected.  The introduction of HAART improves the diversity
of the TCR repertoire via both a thymic regeneration of
naïve cells and a decrease in immune activation, which is
associated with consumption of T-cells.      
THYMIC FUNCTION
It is a long-held view that thymic function decreases with
age and is not present at all in adults.  This view has been
challenged in recent times.6 It has been observed in HIV-
infected persons that thymic responses occur as measured
Fig. 3. TH1 and TH2 model.
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by increase in thymic size in patients on treatment and also
by an increased thymic output of naïve cells.
The benefits of HAART can be shown not only in the clinical
context but also by following certain laboratory parameters
that relate to immune function.  The introduction of HAART
has led to a marked decrease in the incidence of
opportunistic infections and it has also been shown that
certain categories of opportunistic disease may disappear
without specific therapies.  Complete or partial resolution
has been reported in the following conditions:
■ progressive multifocal encephalopathy
■ Kaposi’s sarcoma




After commencement of HAART there are at least two
phases of changing numbers of circulating lymphoid cells.
The first-phase increase in the CD4+ cells is composed of
memory cells that lack markers of cell proliferation,
suggesting that these cells have been redistributed from
other lymphoid sites into the general circulation.  This
comes about as a result of suppression of viral replication
in lymphoid tissue and CD4+ lymphocytes are thus ‘freed’
from being sequestered in these sites.  The early (often
impressive) CD4+ lymphocyte increases are therefore
mainly composed of memory cells.  This is supported by
measuring the expression of the KI67 antigen, which is
selectably expressed in proliferating cells.  This nuclear
antigen was only found to be present after 2 - 3 months on
HAART, suggesting that new lymphocyte proliferation
begins at this time.7
The rapid initial increase of peripheral blood CD4+
lymphocytes is of the order of 1 to 5 cells/µl/day.  Since the
peripheral blood lymphocytes represent only 2% of the
total lymphocyte compartment a minimal virus reduction
in lymph tissue following HAART mobilises enough CD4+
cells to substantially increase the peripheral numbers.  This
phenomenon is more noticeable when treatment is
commenced during late-stage disease.  
The second-phase increase in T-cells is a much slower
process and involves an increase in naïve cells, which
require programming in the thymus gland and also possibly
in some, as yet undefined, extra-thymic sites.  These cells
therefore represent a true and meaningful restoration of
the immune system.  Direct evidence for a thymic
participation is the T-cell regenerative process provided by
the detection in CD45RA+ T cells of DNA circles produced
by TCR rearrangements during thymic maturation.  These T-
cell receptor excision circles (TRECs) can be quantified by
polymerase chain reacton (PCR) and are a good measure of
thymic output of naïve cells.  Another measure of active
thymus involvement involves a measure of thymic size by
imaging, utilising a CT scan.  
Another consequence of the introduction of HAART is a
decrease in the high level of immune activation.  This can
be demonstrated by a reduction and expression of the
memory HLA-DR and CD38 activation markers on both
CD4+ and CD8+ T cells.  A reduction in the expression of
Fas was also observed.8 Fas is an expression marker of cells
undergoing apoptosis.  There is also a return of markers
indicating immune competence and function of T-helper
cells such as CD28 and CD7.   The return of memory CD4+
cell reactivities against pathogens such as CMV and
Mycobacterium tuberculosis can lead to an immune
reconstitution inflammatory syndrome.
Ultimately the reconstitution of the immune response can
lead to the discontinuation of primary or secondary
chemoprophylaxis for opportunistic pathogens.  One of the
disappointing features of immune restoration is the lack of
increase of CD4+ helper cells specific for HIV.  In a few
patients treatment initiated at the time of primary
IMMUNOLOGICAL CHANGES WITH DISEASE
PROGRESSION
■ Decreased CD4+ lymphocyte count
■ Increased CD8+ lymphocyte count (from sero-
conversion to late-stage disease)
■ Decreased naïve CD4+ lymphocytes (CD45RA)
■ Decreased memory CD4+ lymphocytes (CD45RO)
■ Increased activation markers 
Increased HLA-DR on CD8+ lymphocytes
Increased CD38+ on CD8+ lymphocytes
■ Decreased HIV–specific CD4+ lymphocytes
■ Decreased TCR repertoire diversity
■ Switch from TH1 to TH2 cytokine profile














Fig. 4. HIV immune reconstitution.
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infection can preserve this important cell group.  These
cells, it is to be emphasised, are the key to a co-ordinated
immune response and their loss leads to significant
immune disregulation.   
Within the first few weeks of commencing ART, the
immune system begins to recover and may respond to
certain infections that have been present in tissues in a
dormant form.  With the recovery of the immune system
the antigens become recognised and an acute
inflammatory response ensues.  
This situation is seen when patients begin treatment when
their CD4 counts are very low, usually < 50 cells/µl. For
patients with tuberculosis, the syndrome is characterised
by fevers, lymphadenopathy, worsening pulmonary lesions
and expanding CNS lesions. These reactions are commonest
in the intensive phase of treatment and are typically self-
limiting.  
IRIS has been described in the following situations:
■ cytomegalovirus (CMV) retinitis
■ mycobacterial disease
■ hepatitis B or C
■ cryptococcal meningitis.
It has been noted in the clinical situation that 15 - 20% of
new AIDS diagnoses occur in the first few months after
commencement of HAART in patients whose CD4 counts
are < 50/µl.  It is important that HAART should not be
discontinued just because the patient develops an immune
reconstitution syndrome, and steroids may be useful to
suppress the acute inflammatory response.    
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MARKERS OF IMMUNE RECONSTITUTION AFTER
HAART
■ Increase in CD4+ memory cells (CD45RO)
■ Increase in naïve CD4+ cells (CD45RA62L+)
■ Increase in CD8+ naïve cells (CD45RO)
■ Decrease in activation markers (CD38 and HLA-DR)
■ Increase in TCR repertoire 
■ Increase in T-cell receptor excision circles (TRECs)
■ Cytokine profile — TH1-response restored.
■ Improved lymph node architecture
■ Renewed responses to antigens
IMMUNE RECONSTITUTION INFLAMMATORY
SYNDROME (IRIS)
